Your email has been successfully added to our mailing list.

×
0.0508571428571429 0.0857142857142857 0.141142857142857 0.126285714285714 0.0417142857142857 0.104571428571429 0.0914285714285715 0.0571428571428571
Stock impact report

Orphazyme and CytRx skyrocket ahead of FDA decision on Arimoclomol [Seeking Alpha]

Orphazyme A/S (ORPH)  More Company Research Source: Seeking Alpha
PDF Orphazyme and CytRx skyrocket ahead of FDA decision on Arimoclomol [Read more]
Impact snapshot Event time: ORPH
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ORPH alerts
from News Quantified
Opt-in for
ORPH alerts

from News Quantified
Opt-in for
ORPH alerts

from News Quantified